Prospective Longitudinal Assessment of Health-related Quality of Life in Patients With Brain Metastases Undergoing Radiation Therapy
Conclusions:
Patients receiving SRS versus whole brain RT and systemic therapy reported better posttreatment hrQoL. In addition, melanoma metastases, nonmarried, male, and older patients with reported better hrQoL in various as well as domains after intracranial RT.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Central Nervous System Source Type: research
More News: Alopecia | Brain | Brain Cancers | Brain Tumor | Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Lung Cancer | Melanoma | Neurology | Pain | Radiation Therapy | Skin Cancer